Antiobesity Medications: Expert Discusses Older, Newer Therapies

News
Video

Obesity specialist Sandra Christensen, MSN, ARNP, details the differences between older antiobesity medications and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.

How do older antiobesity medications, such as bupropion/naltrexone, phentermine/topirimate, and orlistat differ from the more recently approved GLP-1RAs liraglutide and semaglutide 2.4 mg?

Was a question Patient Care Online asked medical weight management specialist Sandra Christensen, MSN, ARNP, in a recent interview on antiobesity medications.

In the video below, Ms Christensen gives a primer on common antiobesity medications and discusses the differences between older antiobesity medications and newer GLP-1RA therapies.

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
© 2024 MJH Life Sciences

All rights reserved.